Your search matched 4 results
While pharmaceutical manufacturers need to continue engaging with the broader healthcare system to help address healthcare disparities in the long term, there is action they can take now.
For many patients, receiving care right away is of vital importance.
CMS has recently finalized a rule that aims to save beneficiaries and pharmaceutical manufactures money.
Financial toxicity decreases cancer patients’ quality of life – but early identification and strategic planning can mitigate the impact overall.